The effect of Nipped-B-like (Nipbl) haploinsufficiency on genome-wide cohesin binding and target gene expression: modeling Cornelia de Lange syndrome
Open Access
- 25 August 2017
- journal article
- research article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 9 (1) , 1-20
Abstract
Cornelia de Lange syndrome (CdLS) is a multisystem developmental disorder frequently associated with heterozygous loss-of-function mutations of Nipped-B-like (NIPBL), the human homolog of Drosophila Nipped-B. NIPBL loads cohesin onto chromatin. Cohesin mediates sister chromatid cohesion important for mitosis but is also increasingly recognized as a regulator of gene expression. In CdLS patient cells and animal models, expression changes of multiple genes with little or no sister chromatid cohesion defect suggests that disruption of gene regulation underlies this disorder. However, the effect of NIPBL haploinsufficiency on cohesin binding, and how this relates to the clinical presentation of CdLS, has not been fully investigated. Nipbl haploinsufficiency causes CdLS-like phenotype in mice. We examined genome-wide cohesin binding and its relationship to gene expression using mouse embryonic fibroblasts (MEFs) from Nipbl+/− mice that recapitulate the CdLS phenotype. We found a global decrease in cohesin binding, including at CCCTC-binding factor (CTCF) binding sites and repeat regions. Cohesin-bound genes were found to be enriched for histone H3 lysine 4 trimethylation (H3K4me3) at their promoters; were disproportionately downregulated in Nipbl mutant MEFs; and displayed evidence of reduced promoter-enhancer interaction. The results suggest that gene activation is the primary cohesin function sensitive to Nipbl reduction. Over 50% of significantly dysregulated transcripts in mutant MEFs come from cohesin target genes, including genes involved in adipogenesis that have been implicated in contributing to the CdLS phenotype. Decreased cohesin binding at the gene regions is directly linked to disease-specific expression changes. Taken together, our Nipbl haploinsufficiency model allows us to analyze the dosage effect of cohesin loading on CdLS development.Keywords
All Related Versions
Funding Information
- National Institutes of Health (HD052860, HD052860, HG006870, HD062951, T32 CA113265, T15LM07443, T32 CA09054)
- California Institute of Regenerative Medicine (TB1-01182)
This publication has 91 references indexed in Scilit:
- RAD21 Mutations Cause a Human CohesinopathyThe American Journal of Human Genetics, 2012
- The Ancient and Evolving Roles of Cohesin in Gene Expression and DNA RepairCurrent Biology, 2012
- Waves of Retrotransposon Expansion Remodel Genome Organization and CTCF Binding in Multiple Mammalian LineagesCell, 2012
- Cohesin Selectively Binds and Regulates Genes with Paused RNA PolymeraseCurrent Biology, 2011
- Cohesin: genomic insights into controlling gene transcription and developmentCurrent Opinion in Genetics & Development, 2011
- New insights into the function of transcription factor TFIID from recent structural studiesCurrent Opinion in Genetics & Development, 2011
- Architectural roles of multiple chromatin insulators at the human apolipoprotein gene clusterThe EMBO Journal, 2009
- Cohesins localize with CTCF at the KSHV latency control region and at cellular c‐myc and H19/Igf2 insulatorsThe EMBO Journal, 2008
- Generalized linear mixed models: a review and some extensionsLifetime Data Analysis, 2007
- Association of cohesin and Nipped-B with transcriptionally active regions of the Drosophila melanogaster genomeChromosoma, 2007